Dondoni and Marra
N,N-diisopropylethylamine (175 µL, 1.00 mmol), CuI (9.5 mg, 0.05
mmol), and anhydrous toluene (2 mL) was sonicated in an
ultrasound cleaning bath for 1 min, then magnetically stirred in
the dark at room temperature for 18 h, diluted with AcOEt (100
mL), washed with 1 M phosphate buffer at pH 7 (2 × 10 mL),
dried (Na2SO4), and concentrated. The residue was eluted from a
column of silica gel with 2:1 cyclohexane/AcOEt to give 3a (136
mg, 73%) as a white foam; [R]D ) +3.9 (c 1.0, CHCl3). 1H NMR
(400 MHz): δ 7.36-7.24 and 7.18-7.14 (2m, 38H, Ar, 2 H-5 Tr.),
7.01-6.97 (m, 4H, Ar), 6.55 and 6.53 (2d, 4H, J ) 1.8 Hz, Ar
calix.), 6.49-6.47 (m, 6H, Ar calix.), 4.96 and 4.91 (2d, 4H, J )
11.2 Hz, 2 PhCH2), 4.86 and 4.57 (2d, 4H, J ) 10.8 Hz, 2 PhCH2),
4.64 and 4.32 (2d, 4H, J ) 10.8 Hz, 2 PhCH2), 4.56 and 4.51 (2d,
4H, J ) 12.4 Hz, 2 PhCH2), 4.54 (d, 2H, J1,2 ) 9.8 Hz, 2 H-1),
4.42 and 4.41 (2d, 4H, J ) 13.2 Hz, 4 Hax of ArCH2Ar), 4.16 and
4.05 (2dt, 4H, J ) 7.2, 13.8 Hz, 2 ArCH2CH2CH2), 3.99 (dd, 2H,
J2,3 ) 9.0 Hz, 2 H-2), 3.87-3.79 (m, 8H, 4 CH3CH2CH2O), 3.83
5,17-Bis{3-[4-(â-D-glucopyranosyl)-1H-1,2,3-triazol-1-yl]-
propyl}-25,26,27,28-tetrapropoxy-calix[4]arene (3c). A solution
of 3b (29 mg, 0.02 mmol) in a 0.2 M solution of NaOMe in MeOH
(4 mL, prepared from Na and MeOH immediately before the use)
was kept at room temperature for 2 h in a nitrogen atmosphere,
then neutralized with Amberlite IR-120 resin (H+ form, activated
and washed with H2O and MeOH immediately before the use), and
filtered through a sintered glass filter. The resin was washed with
MeOH, and the solution was concentrated and dried under high
vacuum to give 3c (21 mg, 94%) as an amorphous solid; [R]D
)
1
+6.6 (c 1.0, MeOH). H NMR (300 MHz, CD3OD): δ 7.84 (bs,
2H, 2 H-5 Tr.), 6.75 (d, 4H, J ) 7.5 Hz, Ar), 6.64 (t, 2H, J ) 7.5
Hz, Ar), 6.45 (s, 4H, Ar), 4.48 and 3.14 (2d, 8H, J ) 13.2 Hz, 4
ArCH2Ar), 4.46-4.42 (m, 2H, 2 H-1), 4.18 (t, 4H, J ) 6.7 Hz, 2
ArCH2CH2CH2), 3.93 (t, 4H, J ) 7.5 Hz, 2 CH3CH2CH2O), 3.92-
3.88 (m, 2H, 2 H-6a), 3.81 (t, 4H, J ) 7.5 Hz, 2 CH3CH2CH2O),
3.71 (dd, 2H, J5,6b ) 4.0, J6a,6b ) 12.0 Hz, 2 H-6b), 3.66-3.42 (m,
8H), 2.16 (t, 4H, J ) 7.0 Hz, 2 ArCH2CH2CH2), 2.08-1.90 (m,
12H, 4 CH3CH2CH2O, 2 ArCH2CH2CH2), 1.06 and 1.03 (2t, 12H,
J ) 7.5 Hz, 4 CH3CH2CH2O). 13C NMR (75 MHz, CD3OD): δ
157.8 (C), 156.1 (C), 147.2 (C), 136.5 (C), 135.9 (C), 134.9 (C),
129.4 (CH), 129.2 (CH), 124.9 (CH), 123.2 (CH), 82.2 (CH), 79.6
(CH), 78.1 (CH2), 77.8 (CH2), 75.6 (CH), 75.0 (CH), 71.6 (CH),
63.0 (CH2), 50.7 (CH2), 32.9 (CH2), 32.7 (CH2), 31.9 (CH2), 24.5
(CH2), 24.4 (CH2), 10.9 (CH3), 10.7 (CH3). MALDI-TOF MS
(dd, 2H, J3,4 ) 9.0 Hz, 2 H-3), 3.75 (dd, 2H, J5,6a ) 1.8, J6a,6b
)
10.8 Hz, 2 H-6a), 3.72 (dd, 2H, J4,5 ) 9.6 Hz, 2 H-4), 3.70 (dd,
2H, J5,6b ) 4.5 Hz, 2 H-6b), 3.65 (ddd, 2H, 2 H-5), 3.09 and 3.08
(2d, 4H, J ) 13.2 Hz, 4 Heq of ArCH2Ar), 2.34 and 2.26 (2dt, 4H,
J ) 7.2, 14.0 Hz, 2 ArCH2CH2CH2), 2.02 (tt, 4H, J ) 7.2, 7.2 Hz,
2 ArCH2CH2CH2), 1.97-1.88 (m, 8H, 4 CH3CH2CH2O), 1.02 and
0.98 (2t, 12H, J ) 7.5 Hz, 4 CH3CH2CH2O). 13C NMR (75 MHz):
δ 156.1 (C), 155.4 (C), 145.4 (C), 138.6 (C), 138.0 (C), 135.4 (C),
134.6 (C), 133.0 (C), 128.4 (CH), 128.3 (CH), 128.2 (CH), 128.0
(CH), 127.8 (CH), 127.7 (CH), 127.6 (CH), 123.0 (CH), 122.1 (CH),
86.9 (CH), 81.8 (CH), 79.4 (CH), 78.2 (CH), 76.6 (CH2), 75.6
(CH2), 75.1 (CH2), 74.8 (CH2), 74.0 (CH), 73.4 (CH2), 69.2 (CH2),
49.3 (CH2), 31.8 (CH2), 31.7 (CH2), 30.9 (CH2), 23.2 (CH2), 23.1
(CH2), 10.4 (CH3), 10.2 (CH3). MALDI-TOF MS (1856.38): 1858.5
(M+ + 2H), 1880.5 (M+ + H + Na), 1896.5 (M+ + H + K).
Anal. Calcd for C118H130N6O14: C, 76.37; H, 7.06; N, 4.53.
Found: C, 76.10; H, 6.91; N, 4.33.
(1135.38): 1136.5 (M+ + H), 1158.5 (M+ + Na), 1174.5 (M+
+
K). Anal. Calcd for C62H82N6O14: C, 65.59; H, 7.28; N, 7.40.
Found: C, 65.30; H, 7.19; N, 7.25.
5,11,17,23-Tetrakis(3-azidopropyl)-25,26,27,28-tetrapropoxy-
calix[4]arene (4). A mixture of known1a 5,11,17,23-tetrakis(3-
hydroxypropyl)-25,26,27,28-tetrapropoxy-calix[4]arene (412 mg,
0.50 mmol), sodium azide (260 mg, 4.00 mmol), diphenyl phos-
phoryl azide (640 µL, 3.00 mmol), 1,8-diazabicyclo[5.4.0.]undec-
7-ene (300 µL, 2.00 mmol), and anhydrous DMF (5 mL) was stirred
at 120 °C for 14 h, then cooled to room temperature, diluted with
Et2O (150 mL), washed with H2O (2 × 10 mL), dried (Na2SO4),
and concentrated. The residue was eluted from a column of silica
gel with 9:1 cyclohexane/AcOEt to give 4 (412 mg, 89%) as a
5,17-Bis{3-[4-(2,3,4,6-tetra-O-acetyl-â-D-glucopyranosyl)-1H-
1,2,3-triazol-1-yl]propyl}-25,26,27,28-tetrapropoxy-calix[4]-
arene (3b). The cycloaddition between diazide 2 (76 mg, 0.10
mmol) and alkyne 1b (71 mg, 0.20 mmol) was carried out as
described for the preparation of 3a to give, after column chroma-
tography on silica gel (2.5:1 AcOEt/cyclohexane), 3b (141 mg,
1
syrup. H NMR (300 MHz): δ 6.47 (s, 8H, Ar), 4.42 and 3.08
(2d, 8H, J ) 13.0 Hz, 4 ArCH2Ar), 3.86-3.81 (m, 8H, 4 CH3-
CH2CH2O), 3.18 (t, 8H, J ) 6.8 Hz, 4 CH2CH2CH2N3), 2.39 (t,
8H, J ) 7.5 Hz, 4 CH2CH2CH2N3), 2.02-1.89 (m, 8H, 4 CH3CH2-
CH2O), 1.73 (tt, 8H, J ) 6.8, 7.5 Hz, 4 CH2CH2CH2N3), 1.00 (t,
12H, J ) 7.5 Hz, 4 CH3CH2CH2O). 13C NMR (75 MHz): δ 154.8
(C), 134.7 (C), 133.8 (C), 128.0 (CH), 76.8 (CH2), 50.6 (CH2),
32.0 (CH2), 30.9 (CH2), 30.5 (CH2), 23.2 (CH2), 10.3 (CH3).
MALDI-TOF MS (925.20): 947.9 (M+ + Na). Anal. Calcd for
C52H68N12O4: C, 67.51; H, 7.41; N, 18.17. Found: C, 67.17; H,
7.22; N, 17.91.
1
96%) as a syrup; [R]D ) -22.5 (c 1.0, CHCl3). H NMR (400
MHz, C6D6): δ 7.06 (s, 2H, 2 H-5 Tr.), 6.74-6.68 (m, 6H, Ar),
6.63-6.60 (m, 4H, Ar), 5.56-5.50 (m, 4H, 2 H-2, 2 H-3), 5.50-
5.44 (m, 2H, 2 H-4), 4.81-4.76 (m, 2H, 2 H-1), 4.55 (d,
4H, J ) 13.0 Hz, 4 Hax of ArCH2Ar), 4.39 (dd, 2H, J5,6a ) 4.5,
J6a,6b ) 12.6 Hz, 2 H-6a), 3.97 (dd, 2H, J5,6b ) 2.2 Hz, 2 H-6b),
3.89-3.85 (m, 4H, 2 CH3CH2CH2O), 3.79 (t, 4H, J ) 7.3 Hz, 2
CH3CH2CH2O), 3.67 and 3.60 (2dt, 4H, J ) 7.0, 13.8 Hz, 2 ArCH2-
CH2CH2), 3.31 (ddd, 2H, J4,5 ) 9.5 Hz, 2 H-5), 3.20 and 3.19 (2d,
4H, J ) 13.0 Hz, 4 Heq of ArCH2Ar), 2.14-2.02 (m, 4H, 2 ArCH2-
CH2CH2), 1.97-1.84 (m, 8H, 4 CH3CH2CH2O), 1.71, 1.68, 1.67,
and 1.64 (4s, 24H, 8 Ac), 1.70-1.63 (m, 4H, 2 ArCH2CH2CH2),
5,11,17,23-Tetrakis{3-[4-(2,3,4,6-tetra-O-benzyl-â-D-glucopyrano-
syl)-1H-1,2,3-triazol-1-yl]propyl}-25,26,27,28-tetrapropoxy-calix[4]arene
(5a). The calix[4]arene tetraazide 4 (92 mg, 0.10 mmol) was
allowed to react with 1a (220 mg, 0.40 mmol) in the presence of
freshly distilled N,N-diisopropylethylamine (350 µL, 2.00 mmol)
and CuI (19 mg, 0.10 mmol) as described for the preparation of 3a
to give, after column chromatography on silica gel (from 3:1 to
1:1 cyclohexane/AcOEt), 5a (197 mg, 63%) as a white foam; [R]D
1
0.91 and 0.86 (2t, 12H, J ) 7.5 Hz, 4 CH3CH2CH2O). H NMR
(400 MHz, CDCl3) selected data: δ 7.54 (s, 2H, 2 H-5 Tr.), 6.55
(s, 4H, Ar), 6.49-6.46 (m, 6H, Ar), 5.36 (dd, 2H, J2,3 ) 9.4, J3,4
) 9.0 Hz, 2 H-3), 5.30 (dd, 2H, J1,2 ) 9.5 Hz, 2 H-2), 5.19 (dd,
2H, J4,5 ) 9.9 Hz, 2 H-4), 4.79 (d, 2H, 2 H-1), 4.42 and 3.10 (2d,
1
8H, J ) 13.2 Hz, 4 ArCH2Ar), 4.30 (dd, 2H, J5,6a ) 5.0, J6a,6b
)
) -3.8 (c 1.0, CHCl3). H NMR (400 MHz): δ 7.41 (s, 4H, 4
12.8 Hz, 2 H-6a), 4.23-4.15 (m, 4H, 2 ArCH2CH2CH2), 4.12 (dd,
2H, J5,6b ) 2.0 Hz, 2 H-6b), 3.88 (ddd, 2H, 2 H-5). 13C NMR (75
MHz): δ 170.6, 170.2, and 169.5 (CO), 156.1 and 155.5 (C Ar),
143.9 (C-4 Tr.), 135.5, 134.5, and 133.0 (C Ar), 128.1 and 127.8
(CH Ar), 122.2 (C-5 Tr.), 122.0 (CH Ar), 76.7 (CH3CH2CH2O),
76.2 (CH), 74.0 (CH), 73.4 (CH), 71.2 (CH), 68.4 (CH), 62.1 (C-
6), 49.7 (ArCH2CH2CH2), 31.8 (CH2), 31.7 (CH2), 30.9 (CH2), 23.2
(CH2), 23.1 (CH2), 20.7 and 20.6 (CH3CO), 10.4 and 10.1 (CH3-
CH2CH2O). MALDI-TOF MS (1471.68): 1473.3 (M+ + H), 1496.2
(M+ + H + Na), 1511.2 (M+ + K). Anal. Calcd for C78H98N6O22:
C, 63.66; H, 6.71; N, 5.71. Found: C, 63.39; H, 6.60; N, 5.56.
H-5 Tr.), 7.34-7.22 (m, 52H, Ar), 7.16-7.10 (m, 20H, Ar), 6.97-
6.94 (m, 8H, Ar), 6.43 (s, 8H, Ar calix.), 4.93 and 4.87 (2d, 8H, J
) 11.3 Hz, 4 PhCH2), 4.84 and 4.55 (2d, 8H, J ) 10.8 Hz, 4
PhCH2), 4.60 and 4.27 (2d, 8H, J ) 10.8 Hz, 4 PhCH2), 4.52 and
4.46 (2d, 8H, J ) 12.4 Hz, 4 PhCH2), 4.51 (d, 4H, J1,2 ) 9.2 Hz,
4 H-1), 4.39 and 3.04 (2d, 8H, J ) 13.0 Hz, 4 ArCH2Ar), 4.14-
4.06 (m, 8H, 4 ArCH2CH2CH2), 3.95 (dd, 4H, J2,3 ) 9.4 Hz, 4 H-2),
3.82 (t, 8H, J ) 7.5 Hz, 4 CH3CH2CH2O), 3.80 (dd, 4H, J3,4 ) 8.3
Hz, 4 H-3), 3.74-3.66 (m, 12H), 3.64-3.59 (m, 4H), 2.27 (t, 8H,
J ) 7.2 Hz, 4 ArCH2CH2CH2), 1.97-1.87 (m, 16H, 4 ArCH2CH2-
CH2, 4 CH3CH2CH2O), 0.98 (t, 12H, J ) 7.5 Hz, 4 CH3CH2CH2O).
7552 J. Org. Chem., Vol. 71, No. 20, 2006